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Abstract
Background: Scabies is a disease of worldwide significance, causing considerable morbidity in both humans and other
animals. The scabies mite Sarcoptes scabiei burrows into the skin of its host, obtaining nutrition from host skin and blood.
Aspartic proteases mediate a range of diverse and essential physiological functions such as tissue invasion and migration,
digestion, moulting and reproduction in a number of parasitic organisms. We investigated whether aspartic proteases may
play role in scabies mite digestive processes.
Methodology/Principle Findings: We demonstrated the presence of aspartic protease activity in whole scabies mite
extract. We then identified a scabies mite aspartic protease gene sequence and produced recombinant active enzyme. The
recombinant scabies mite aspartic protease was capable of digesting human haemoglobin, serum albumin, fibrinogen and
fibronectin, but not collagen III or laminin. This is consistent with the location of the scabies mites in the upper epidermis of
human skin.
Conclusions/Significance: The development of novel therapeutics for scabies is of increasing importance given the
evidence of emerging resistance to current treatments. We have shown that a scabies mite aspartic protease plays a role in
the digestion of host skin and serum molecules, raising the possibility that interference with the function of the enzyme
may impact on mite survival.
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Introduction
Scabies is a disease of worldwide significance, caused by
infestation of the skin with the ‘‘itch mite’’ Sarcoptes scabiei. At the
end of the 20th century, the global burden of scabies in humans
was estimated to be around 300 million cases worldwide [1].
Scabies is also a significant veterinary disease with S. scabiei a
common parasite of economically important livestock, wildlife and
companion animals [2]. Evidence of emerging scabies mite
resistance to ivermectin [3,4,5] and permethrin [6,7] emphasises
the need to develop new anti-parasite therapies. This requires
further understanding of scabies mite biology and host interaction.
Proteases play critical roles in the lifecycles of many parasites. As
a result they are considered to be potential targets for the
development of novel immunotherapeutic, chemotherapeutic, and
serodiagnostic agents. A study investigating the presence of
proteolytic activity in scabies mite extract detected phosphatase,
esterase, aminopeptidase and glycosidase activity [8]. However no
trypsin or chymotrypsin like serine protease activity was detected
in the scabies mite extract, although an active serine protease
sequence had previously been identified among scabies mite
expressed sequence tags [9]. A recombinant active scabies mite
serine protease, designated Sar s 3, was shown to have trypsin like
activity. Recombinant Sar s 3 cleaves human filaggrin in vitro and
co-localises to the mite gut with filaggrin, a key component of the
stratum corneum [10]. The presence of cysteine protease activity
in scabies mite extract has not been investigated however multiple
active as well as putatively inactive cysteine proteases have been
identified among scabies mite expressed sequence tags [11] and
functional analysis of these molecules is underway [12].
Aspartic proteases, which have a pair of aspartic acid residues at
their active site, are known to mediate a range of diverse and
essential physiological functions such as tissue invasion and
migration, digestion, moulting and reproduction in a number of
parasitic organisms. The largest and most widely studied group of
aspartic proteases is the A1 family, which includes the sub-families
of pepsinogen, renin, cathepsin E and cathepsin D. Cathepsin D-
like aspartic proteases are utilised as digestive enzymes by many
haematophagous and phytophagous hemipterans, dipterans, and
coleopterans [13]. Aspartic proteases play a key role in haemoglobin
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proteolysis in a number of parasites including ticks [14], Plasmodium
[15], Schistosoma [16], Onchocerca [17], Haemonchus [18] and
hookworms [19]. A cathepsin D like aspartic protease of the
hookworms Ancylostoma caninum and Necator americanus is expressed in
the oesophagus and intestine of the parasites and digests host
haemoglobin [19]. Schistosoma japonicum and Schistosoma mansoni
possess a cathepsin D like aspartic protease expressed predomi-
nantly in the gastroepidermis that digests haemoglobin in ingested
blood at a pH range of 2.5–4.6 [16]. These cathepsin D molecules
were also found to degrade host IgG, complement C3 and serum
albumin at acidic pH, contributing to the evasion of the host
immune response as it penetrates its host [20]. In the more closely
related context of ectoparasites, extracts of the sheep scab mite
Psoroptes ovis have been shown to have aspartic protease activity that
is partially responsible for the digestion of host fibrinogen and
fibronectin. The enzyme is thought to play an anti-coagulant role by
degrading fibrinogen thus ensuring a continuous flow of serous
exudate from host skin lesions for mite nutrition [21]. An aspartic
protease from the cattle tick Rhipicephalus microplus was demonstrated
to have pepstatin-sensitive activity against haemoglobin and it’s
involvement in vitellin degradation was the first characterisation of
an aspartic protease involved in yolk degradation in an arthropod
[22]. Another aspartic protease in the same organism, designated
tick heme-binding aspartic proteinase, was later shown not only to
degrade vitellin but also to possibly regulate its degradation by
binding heme molecules on the surface of the enzyme [23]. An
aspartic protease from the tickHaemophysalis longicornis expressed as a
recombinant protein was able to digest haemoglobin and showed
elevated expression in the salivary gland and the midgut in response
to a blood meal [24].
Scabies mite extract has been shown to degrade fibronectin,
fibrinogen and haemoglobin [8] however the enzymes responsible
for this were not identified. The presence of aspartic protease
activity in the scabies mite extract was not investigated and the
role that scabies mite aspartic proteases may play in the
degradation of host proteins has not been determined. This study
aimed to investigate aspartic protease activity in the scabies mite
and to determine the role aspartic proteases may play in the
digestion of physiologically relevant host macromolecules.
Methods
Ethics statement
Human scabies mites were harvested from skin collected from
crusted scabies patients admitted to the Royal Darwin Hospital,
Northern Territory, Australia. All participants were given project
information and provided written informed consent prior to skin
collection. Human blood was collected with informed consent
from a healthy volunteer. The project was approved by the
Human Research Ethics Committee of the Northern Territory
Department of Health and the Menzies School of Health
Research, and was conducted in accordance with the Australian
National Health and Medical Research Council’s National
Statement on Ethical Conduct in Human Research.
Preparation of whole scabies mite extract
Human scabies mites were collected in pools of approximately
150 and stored in PBS at 280uC until protein extraction. The
mites were then washed twice with PBS with centrifugation at
13000 g for 5 minutes, resuspended in 100 ul PBS and homog-
enised with a motorised pestle. The suspension was sonicated for
1 minute and the debris pelleted by centrifugation at 17400 g for
30 minutes at 4uC. The supernatant was recovered and the
protein concentration determined by Bradford assay [25] (Bio-Rad
Laboratories, Reagents Park, NSW, Australia).
Aspartic protease activity assays using a fluorogenic
substrate
The fluorogenic substrate MoCAc-Gly-Lys-Pro-Ile-Leu-Phe-
Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH (Sigma Aldrich, Castle Hill,
NSW, Australia) was used to detect aspartic protease activity in the
scabies mite extract. Each 200 ul reaction contained 100 mM
sodium citrate pH 3.5, 20 mM fluorogenic substrate dissolved in
DMSO, 19 mg scabies extract protein or 27.5 nM human
cathepsin D (Sigma Aldrich) and 5 mM pepstatin A (Sigma
Aldrich), where used. The reactions were incubated at 37uC for
5 minutes prior to the addition of the substrate, and for a further
5 minutes if pepstatin A was also used. The fluorescence units
were recorded at 60 second intervals commencing after 10 min-
utes, for three hours at 37uC on a Victor3 fluorometer (Perkin
Elmer, Glen Waverley, Vic, Australia) using 340 nm absorption
and 405 nm emission filters.
Aspartic protease activity assays using haemoglobin as
the substrate
Haemoglobin was extracted from human blood by washing
20 mL of blood twice with three volumes of normal saline with red
cells pelleted by centrifugation at 600 g for 10 minutes. Pelleted
red cells were then lysed by resuspending in four volumes of
hypotonic medium (0.16PBS) and gently mixing for 10 minutes.
Cell debris was removed by centrifugation at 14000 g for
30 minutes. Haemoglobin concentration was measured by Brad-
ford assay and the purity assessed by running on a 15% SDS-
PAGE gel and staining with coomassie brilliant blue R-250 (Sigma
Aldrich). Extracted haemoglobin was stored at 4uC until use. Acid
denatured haemoglobin was prepared by adjusting the pH of the
extracted haemoglobin solution to pH 1.6 with 10.2 M hydro-
chloric acid and incubating at room temperature for 10 minutes
prior to use in haemoglobinolysis assays.
Haemoglobinolysis assays were initially carried out over a pH
range of 3.5–8.5. Sodium citrate was used for making the buffer of
pH 3.5, sodium acetate for buffers of pH 4.5 and 5.5, sodium
phosphate for buffers of pH 6.5 and 7.5 and HEPES for the buffer
of pH 8.5. Reactions contained 100 ug acid denatured haemo-
globin, 19 mg whole scabies mite extract and 100 mM of the
relevant buffer in a final volume of 60 mL. Reactions were
incubated at 37uC for 5 minutes prior to the addition of the
substrate then incubated at 37uC for 2 hours. Protein bands were
visualised by running on a 15% non-reducing SDS-PAGE and
staining with coomassie brilliant blue R-250.
Author Summary
Scabies is an infectious disease of the skin caused by
infestation with the parasitic mite Sarcoptes scabiei. It is a
disease that has a considerable impact on humans and
other animals, including livestock, wildlife and companion
animals. Scabies mites burrow into the skin of their host,
consuming host skin and blood molecules. Aspartic
proteases play a key role in invasion and digestion
processes in many parasitic organisms. We have identified
a scabies mite aspartic protease and have shown that it is
capable of digesting human haemoglobin, serum albumin,
fibrinogen and fibronectin in vitro, indicating that it plays a
role in mite digestive processes. This raises the possibility
that interfering with the function of this digestive enzyme
may impact on mite survival.
Identification of a Scabies Mite Aspartic Protease
PLOS Neglected Tropical Diseases | www.plosntds.org 2 November 2013 | Volume 7 | Issue 11 | e2525
Sequence identification and analysis
An EST dataset of over 40,000 human scabies mite (S. scabiei
var. hominis) sequences [26,27] was analysed using BLASTx [28]
against the GenBank non-redundant database. A single contig of
10 sequences was shown to have homology to known aspartic
proteases. As the contig lacked the 5` end of the gene sequence, the
sequence was completed using a PCR and sequencing based
approach on cDNA libraries using a combination of contig specific
and vector primers. The complete coding sequence was submitted
to GenBank (accession number KC540783). Signal sequence
Figure 1. Detection of aspartic protease activity in scabies mite extract using a fluorescent substrate. The fluorescence signal was
recorded at 60 second intervals, commencing after 10 minutes.
doi:10.1371/journal.pntd.0002525.g001
Figure 2. Digestion of acid denatured haemoglobin by scabies mite extract at pH 3.5–8.5. Haemoglobinolytic activity in whole human
scabies mite extract was detected using acid denatured human haemoglobin (AD-Hb) as substrate at pH 3.5–8.5. Reactions were run on a 15% non-
reducing SDS-PAGE gel and stained with coomassie brilliant blue R-250. Lane 1, molecular weight marker; lane 2, AD-Hb; lanes 3–8, AD-Hb plus
scabies mite extract at pH 3.5, 4.5, 5.5, 6.5, 7.5 and 8.5 respectively.
doi:10.1371/journal.pntd.0002525.g002
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prediction was made using SignalP-HMM [29]. The amino acid
sequence was compared to available sequences on GenBank using
BLASTp [28].
Preparation of enzymatically active recombinant S.
scabiei aspartic protease
The sequence of the S. scabiei aspartic protease truncated by 23
amino acids at the N-terminus (designated N23SsAP) was amplified
from a scabies mite cDNA library [26,27] using the primers (59-39)
F- gCggATCCAAATTATTACgAgTCAAATTgC and R-gCCTgCAgT-
CATTgTgATTgCgTAATg yielding a 1191 bp product. The primers
included restriction enzyme sites (italicised in primer sequences), to
facilitate directional cloning into pQE-9 in frame with the N-
terminal hexa-histidine tag. The plasmid was transformed and
expressed in E.coli strain BL21/pREP4. Cell pellets were resus-
pended in 50 mM Tris, 150 mM NaCl, 1 mM MgCl2, at a
concentration of 1 g cells/5 ml buffer. The cells were lysed by
sonication and inclusion bodies were isolated by layering 18 ml of
the cell lysate over 10 ml of 27% sucrose solution followed by
centrifugation for 45 minutes at 120006g. The pellet was then
resuspended in 50 mM Tris, 150 mM NaCl, 1 mM MgCl2, 1%
Triton X-100 and passed again through a 27% sucrose solution as
described above. The inclusion bodies were resuspended in 20 mM
Tris buffer pH 8.0 at a concentration of 100 mg/ml. Inclusion
bodies were solubilised at 2 mg/ml for 2 hours in denaturation
buffer (8M urea, 50 mMTris, 1 mMDTT, 150 mMNaCl, 10 mM
imidazole, pH 8.5), then the pH adjusted to 7.0 with 4M HCl. The
denatured protein solution was then centrifuged at 80006g for
10 minutes to sediment any precipitates.
A Ni-NTA (Qiagen, Chadstone, Victoria, Australia) column
was equilibrated with five column volumes of the solubilisation
buffer. 25 mg solubilised inclusion bodies were loaded on the
column and mixed for one hour at room temperature. The
column was washed with 10 ml of 8M urea, 50 mM Tris, 1 mM
DTT, 150 mM NaCl, 20 mM imidazole, pH 8.5. Bound histi-
dine-tagged protein was eluted in 1.5 ml fractions with 8M urea,
20 mM Tris, 1 mM DTT, 150 mM NaCl, 250 mM imidazole,
pH 8.5. The purified protein was concentrated using an stirred
cell concentrator with 10 kDa molecular weight cut-off (MWCO)
filter discs (Millipore, Billerica, MA, USA) to a final protein
concentration of 2 mg/ml. The denatured protein was refolded by
adding the protein drop wise to cold refolding buffer (20 mM
NaH2PO4, 20 mM NaCl, 0.3 mM oxidised glutathione, 3 mM
reduced glutathione, 300 mM L-arginine, pH 6.4) over a period of
2 hours to a final protein concentration of 20 mg/ml, with the
refolding buffer stirring at a slow speed at 4uC. The refolding mix
was left standing at 4uC for 24 hours, then the protein was
concentrated in a 10 kDa MWCO centrifuge filter device. The
concentration of the protein was determined by Bradford assay.
The refolded protein was activated by incubating the zymogen
in 0.1M sodium citrate buffer pH 3.5and the activated protease
was visualised by silver staining after separation by SDS-PAGE. A
total of 11 different pH conditions were tested for the determi-
nation of the optimal pH for enzymatic activity of the activated
N23SsAP using the fluorogenic substrate assay described above.
Sodium citrate was used for buffers of pH 2.5–5.5, sodium
phosphate for buffers of pH 6–7.5 and Tris for buffers of pH 8–9.
The highest initial enzyme velocity was designated as 100% and
Figure 3. Production of enzymatically active recombinant N23SsAP. A. N23SsAP was expressed in E. coli and purified over Ni-NTA. The
expressed and purified protein was analysed by SDS-PAGE stained with coomassie brilliant blue R-250. Lane 1, molecular weight marker; lane 2, E. coli
lysate before induction of the protein expression; lane 3, E. coli lysate after induction of the protein expression; lane 4, flow through from the Ni-NTA
column; lane 5, purified N23SsAP eluted from the Ni-NTA column. B. N23SsAP (lane 2) was incubated at pH 3.5 and samples taken after 15 (lane 3)
and 30 minutes (lane 4). Activation of the zymogen was visualised by silver staining after SDS-PAGE. Downward pointing arrow- zymogen; upward
pointing arrow- activated enzyme. C. The activity of the activated enzyme at different pH conditions was measured using a fluorogenic substrate. The
highest initial enzyme velocity was designated as 100% and enzyme velocities at other pHs were calculated as a percentage of this maximum value.
doi:10.1371/journal.pntd.0002525.g003
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enzyme velocities at other pHs were calculated as a percentage of
this maximum value.
Digestion of human haemoglobin and serum albumin by
recombinant N23SsAP
Each 200 ml reaction contained 225 mg human haemoglobin or
62.5 mg human serum albumin, 2.5 mg refolded N23SsAP and
0.1M sodium citrate buffer pH 3.5. The recombinant enzyme was
activated by incubating with the buffer for five minutes at 37uC
prior to the addition of substrate. The reactions were then
incubated at 37uC and samples taken at regular intervals and
analysed on a 15% non-reducing SDS-PAGE gel.
Digestion of human skin macromolecules by
recombinant N23SsAP
Each 80 ml reaction contained 0.1M sodium citrate buffer
pH 3.5, 0.3 mg refolded N23SsAP, 5 mM pepstatin A (where used)
and 10 mg of one of the following substrates: fibrinogen;
fibronectin; collagen III; or laminin. All the substrates were of
human origin (Sigma Aldrich). In the reactions where enzyme
Figure 4. Digestion of human haemoglobin by the recombinant human scabies mite aspartic protease N23SsAP. The
haemoglobinolytic activity of N23SsAP was detected using native human haemoglobin as substrate at pH 3.5. Reactions were run on a 15% non-
reducing SDS-PAGE gel and stained with coomassie brilliant blue R-250. Lane 1, molecular weight marker; lane 2, haemoglobin alone; lanes 3–6,
haemoglobin plus N23SsAP, incubated for 1 hour (lane 3), 2 hours (lane 4), 4 hours (lane 5) or 12 hours (lane 6).
doi:10.1371/journal.pntd.0002525.g004
Figure 5. Digestion of human serum albumin by the recombinant human scabies mite aspartic protease N23SsAP. Recombinant
N23SsAP was tested for its ability to digest human serum albumin. Reactions were run on a 15% non-reducing SDS-PAGE gel and stained with
coomassie brilliant blue R-250. Lane 1, molecular weight marker; lanes 2–6, serum albumin plus N23SsAP, incubated for 15 minutes (lane 2), 1 hour
(lane 3), 2 hours (lane 4), 4 hours (lane 5) or 12 hours (lane 6).
doi:10.1371/journal.pntd.0002525.g005
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activity was required to be blocked, pepstatin A was added to the
activated enzyme reaction for five minutes before the addition of
the substrate. The reactions were incubated at 37uC and samples
were removed after 4 hours and 13 hours and analysed on 12% or
15% non-reducing SDS-PAGE gels.
Results
Analysis of aspartic protease activity in whole scabies
mite extract
Whole scabies mite extract was initially examined for evidence
of aspartic protease activity using a general aspartic protease
fluorogenic substrate. Reactions were conducted at pH 3.5 as
most aspartic proteases are active at an acidic pH. The human
aspartic protease cathepsin D showed cleavage of the fluorescent
substrate immediately, reaching maximum cleavage after 60 min-
utes, with cleavage completely blocked by the general aspartic
protease inhibitor pepstatin A (Figure 1). Cleavage of the
fluorescent substrate by the scabies mite extract was first detected
after 18 minutes and reached the level of cleavage of human
cathepsin D after two hours. Cleavage of the fluorogenic
substrate by the scabies mite extract was blocked by pepstatin
A, indicating the presence of aspartic protease activity in the
whole mite extract.
The ability of scabies mite extract to digest human haemoglobin
was then investigated. Reactions carried out with acid denatured
haemoglobin over a pH range of 3.5–8.5 showed that almost
complete digestion of acid denatured haemoglobin occurred at
pH 3.5, with little or no digestion observed at pH 4.5 or above
(Figure 2). Thus digestion of haemoglobin by the scabies mite
extract occurred almost exclusively at an acidic pH consistent with
digestion by aspartic and or cysteine proteases, as has been shown
for related organisms such as ticks [14].
S. scabiei aspartic protease sequence identification and
analysis
To identify gene(s) encoding aspartic protease activity in the
scabies mite, we analysed a S. scabiei var. hominis expressed
sequence tag dataset [26,27]. A single contig with homology to
aspartic proteases from other organisms was identified. The
sequence was predicted to encode a prepro-enzyme of 419 amino
acids with a mass of 46.28 kDa, and a signal peptide of 22 amino
acids. The deduced amino acid sequence shows many of the
distinguishing features of the A1 family of aspartic proteases
including two homologous lobes each containing a conserved
DTG motif and the conservation of six cysteine residues predicted
to form three characteristic disulphide bonds [30]. Comparison of
the scabies mite aspartic protease pro-enzyme sequence with
Figure 6. Digestion of human fibrinogen by the recombinant human scabies mite aspartic protease N23SsAP. Recombinant N23SsAP
was tested for its ability to digest human fibrinogen. Reactions were run on a 15% non-reducing SDS-PAGE gel and stained with coomassie brilliant
blue R-250. Lane 1, molecular weight marker; lane 2, fibrinogen alone; lanes 3 and 5, fibrinogen plus N23SsAP; lanes 4 and 6, fibrinogen plus N23SsAP
and pepstatin A, after 4 hours incubation (lanes 3 and 4) and 13 hours incubation (lanes 5 and 6).
doi:10.1371/journal.pntd.0002525.g006
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sequences available in GenBank showed that it had greatest
sequence identity to cathepsin D aspartic proteases including from
other Acari, such as the Blo t allergen of the storage mite Blomia
tropicalis (AAX33731, 61% amino acid identity) and the cathepsin
D of the tick Ixodes scapularis (XP_002416518, 54% amino acid
identity). Based on the cleavage site of the pro-segment of human
cathepsin D, the scabies mite aspartic protease has a pro-segment
that is 52 amino acids in length yielding a 345 amino acid mature
polypeptide.
Preparation of enzymatically active N23SsAP
Recombinant S. scabiei aspartic protease lacking the first 23
amino acids of the full protein sequence (N23SsAP) was produced
in E. coli. The protein was expressed in inclusion bodies and
purified over Ni-NTA (Figure 3A). N23SsAP was refolded using a
rapid dilution method and self-activated at pH 3.5 (Figure 3B).
The activity of the recombinant N23SsAP was determined using
the fluorescent substrate assay. N23SsAP shows the characteristic
pH profile of an aspartic protease, with maximum activity in the
range of pH 3.5–4.5 (Figure 3C).
Digestion of blood and skin macromolecules by
recombinant S. scabiei aspartic protease
A number of physiologically relevant blood and skin macro-
molecules were then tested as substrates for N23SsAP. Digestion of
native human haemoglobin into smaller peptides was apparent
after one hour of incubation with N23SsAP, with further digestion
apparent after 12 hours (Figure 4). Evidence of digestion human
serum albumin by N23SsAP was also apparent after one hour,
with considerable digestion observed after 12 hours (Figure 5).
Undigested fibrinogen appeared as a series of bands between 75
and 50 kDa on a 15% SDS-PAGE gel (Figure 6, lane 2). After four
hours of incubation with N23SsAP, much of the fibrinogen was
digested to a size less than 50 kDa (lane 3). After 13 hours
incubation, fibrinogen had undergone substantial digestion (lane
5). The fibrinogen digestion by N23SsAP was inhibited by
pepstatin A (lanes 4 and 6). Similarly, the large molecular weight
fibronectin showed significant digestion by N23SsAP after 4 and
13 hours. This digestion was largely inhibited by the addition of
pepstatin A (Figure 7). No digestion of collagen III (Figure 8) or
laminin (data not shown) was observed, with the substrates
remaining intact after 13 hours incubation with N23SsAP.
Discussion
This study details the first analysis of aspartic protease activity in
scabies mites. The presence of aspartic protease activity in scabies
mite extract was clearly shown using both a fluorescent peptide
and human haemoglobin as substrates. The lag in the activity of
the scabies mite extract supports the possibility that the scabies
mite aspartic protease being present as a zymogen in the mite
extract (Figure 1). The observed lag might also be due to an
unmatched specificity of the scabies mite aspartic protease to the
fluorogenic substrate. The higher rate of cleavage by human
cathepsin D might be due to the fact that the cleavage of the
Figure 7. Digestion of human fibronectin by the recombinant human scabies mite aspartic protease N23SsAP. Recombinant N23SsAP
was tested for its ability to digest human fibronectin. Reactions were run on a 15% non-reducing SDS-PAGE gel and stained with coomassie brilliant
blue R-250. Lane 1, molecular weight marker; lane 2, fibrinonectin alone; lanes 3 and 5, fibrinonectin plus N23SsAP; lanes 4 and 6, fibrinonectin plus
N23SsAP and pepstatin A, after 4 hours incubation (lanes 3 and 4) and 13 hours incubation (lanes 5 and 6).
doi:10.1371/journal.pntd.0002525.g007
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fluorescent substrate is between a Phe-Phe bond, which matches
the specificity of human cathepsin D. While the A1 family of
aspartic proteases generally has a cleavage site between two
hydrophobic residues, neither the concentration nor the specificity
of the aspartic protease present in the scabies mite extract is
currently known. The preference of scabies mite extract to digest
haemoglobin at an acidic pH is consistent with aspartic protease
activity.
A single S. scabiei aspartic protease gene was identified, with
sequence analysis revealing that the gene encoded a cathepsin D
like enzyme. Despite subsequent analysis of a large EST dataset
and PCR based approaches using degenerate primers designed to
the highly conserved active site regions on scabies mite cDNA
and DNA, no further genes encoding aspartic proteases were
identified (data not shown). Thus while the presence of further
genes encoding aspartic proteases cannot be ruled out, the
present data suggest that scabies mites may possess a single
aspartic protease gene. This is in contrast to other mammalian
parasites such as ticks, hookworms, schistosomes and malaria
parasites, where aspartic proteases are expressed as a family of
enzymes. For example, although there is high sequence identity
among the plasmepsin family of aspartic proteases of the malaria
parasite Plasmodium, their substrate specificity and response to
inhibitors differ [31]. Of the three aspartic protease paralogues
identified in the tick Ixodes ricinus, only one is exclusively expressed
in the gut, where it is involved in haemoglobin digestion [32],
indicating other potential roles for the other paralogues. Thus
competitive and selective inhibition of aspartic protease activity in
these parasites is a challenging task. The presence of a single
aspartic protease in the scabies mite would not present such
complexity.
In this study, recombinant S. scabiei aspartic protease N23SsAP
was shown to digest human haemoglobin, serum albumin,
fibrinogen and fibronectin. A previous study of enzymatic activity
in scabies mite extract, which did not investigate aspartic protease
activity, reported the absence of lipase activity in the scabies mite
extract pointing towards a non-lipid source of nutrition [8].
Although the exact source of nutrition for scabies mites has not
been conclusively demonstrated, abundant proteins such as
haemoglobin and serum albumin are expected to be major
sources of amino acids. Canine scabies mites have been shown to
have longer in vitro survival times on diets that contain serum [33].
Similar to Psoroptes mites, the digestion of fibronectin and
fibrinogen by scabies mites could perform an anti-coagulation
function ensuring the availability of serous material containing
albumin and haemoglobin. The recombinant N23SsAP was
unable to digest human collagen III and laminin in these
experiments. These skin molecules form part of the basement
membrane and may represent the boundary that restricts scabies
mites to the epidermal layer of human skin.
The role of aspartic proteases in pathogenic processes has been
established for a number of parasites. The essential nature of these
enzymes in the lifecycle of some parasites has made them targets of
drug discovery and vaccine development efforts. For example,
monoclonal antibodies against the R. microplus yolk pro-cathepsin
inoculated into cattle were able to produce partial protection
against challenge with R. microplus larvae [34]. Subsequent
vaccination trials with recombinant yolk pro-cathepsin induced
Figure 8. Digestion of human collagen III by the recombinant human scabies mite aspartic protease N23SsAP. Recombinant N23SsAP
was tested for its ability to digest human collagen III. Reactions were run on a 15% non-reducing SDS-PAGE gel and stained with coomassie brilliant
blue R-250. Lane 1, molecular weight marker; lane 2, collagen III alone; lanes 3 and 5, collagen III plus N23SsAP; lanes 4 and 6, collagen III plus
N23SsAP and pepstatin A, after 4 hours incubation (lanes 3 and 4) and 13 hours incubation (lanes 5 and 6).
doi:10.1371/journal.pntd.0002525.g008
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an overall protection of 25% against challenge with R. microplus
larvae [35]. An aspartic protease from the human hookworm N.
americanus was shown to be efficacious as a vaccine against
subsequent hookworm challenge in dogs with lower adult parasite
burdens and reduced host blood loss observed in vaccinated
animals [36,37]. Peptides from the N. americanus aspartic protease
induced neutralising antibodies in mice that inhibited the
enzymatic activity of the protease [38,39]. The development of
novel therapeutics for scabies is of increasing importance given the
evidence of emerging resistance to current treatments. We have
shown that a scabies mite aspartic protease is able to digest human
skin and serum molecules, raising the possibility that interference
with the function of the enzyme may impact on mite survival.
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